Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 64.82 CNY -4.11% Market Closed
Market Cap: 48.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hangzhou Tigermed Consulting Co Ltd
Common Stock Peer Comparison

Comparables:
603259
300759
2269
1548
W
2268

Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Common Stock
ÂĄ864.9m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
15%
WuXi AppTec Co Ltd
SSE:603259
Common Stock
ÂĄ2.9B
CAGR 3-Years
0%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Common Stock
ÂĄ1.8B
CAGR 3-Years
31%
CAGR 5-Years
22%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Common Stock
ÂĄ228k
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Genscript Biotech Corp
HKEX:1548
Common Stock
$2.1m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Common Stock
ÂĄ390k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Common Stock?
Common Stock
864.9m CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Common Stock amounts to 864.9m CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
15%

Over the last year, the Common Stock growth was -1%.

Back to Top